Clinical Trial Update: Personalized Peptide Vaccine in Treating Patients With Advanced Pancreatic Cancer or Colorectal Cancer [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating a Personalized Peptide Vaccine for advanced colorectal cancer and pancreatic cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Pancreatic Cancer

Drugs mentioned

• Personalized Peptide Vaccine

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Metastatic Colorectal Adenocarcinoma, Metastatic Pancreatic Ductal Adenocarcinoma | Phase 1 | Status: RECRUITING